← Leaderboards
Mark A Green
Purdue University West Lafayette
$4,676,661
Attributed
$7,229,403
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $591.4K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$7,229,403 · 4
By mechanism
R01$7,229,403 · 4
Top collaborators
- Gary D Hutchins6 shared
- James W Fletcher4 shared
- Jeffrey L Lacy4 shared
Most similar at Purdue University West Lafayette
Same institution · by research overlap
- William A. Cramer$9,217,448
- James C Fleet$8,467,875
Others in their field
Top investigators on “Copper”
- Svetlana Lutsenko · Oregon Health And Science University$18,045,733
- Kenneth D. Karlin · Johns Hopkins University$16,339,237
- Stephen L Buchwald · Massachusetts Institute Of Technology$15,093,202
- Ninian J Blackburn · Oregon Graduate Institute Science &Tech$14,898,278
- Michael J Petris · University Of Missouri-Columbia$14,851,498
- Edward I Solomon · Stanford University$13,845,825
Research focus
CopperTumorClinical ApplicationTracerProductionTechnologyMulti-Institutional Clinical TrialImaging ModalityMetabolismMeasurementPerfusionPhysiologySiteResponseUniversitiesClinically RelevantImageHead And Neck CancerAthymic MouseIndianaBaseMalignant NeoplasmsNeoplasm MetastasisValidation
Grant awards (21)
Integrated Tools for Quantitative Whole-Body Tumor Perfusion Imaging$450,480
R01 · FY2021 · CA
Integrated Tools for Quantitative Whole-Body Tumor Perfusion Imaging$572,776
R01 · FY2020 · CA
Integrated Tools for Quantitative Whole-Body Tumor Perfusion Imaging$28,832
R01 · FY2019 · CA
Integrated Tools for Quantitative Whole-Body Tumor Perfusion Imaging$560,193
R01 · FY2018 · CA
Integrated Tools for Quantitative Whole-Body Tumor Perfusion Imaging$566,413
R01 · FY2017 · CA
Integrated Tools for Quantitative Whole-Body Tumor Perfusion Imaging$591,408
R01 · FY2016 · CA
Whole-Body PET/CT Assessment of Tumor Perfusion Using Generator-Produced 62Cu$416,149
R01 · FY2012 · CA
Whole-Body PET/CT Assessment of Tumor Perfusion Using Generator-Produced 62Cu$420,747
R01 · FY2011 · CA
Whole-Body PET/CT Assessment of Tumor Perfusion Using Generator-Produced 62Cu$437,758
R01 · FY2010 · CA
Whole-Body PET/CT Assessment of Tumor Perfusion Using Generator-Produced 62Cu$476,882
R01 · FY2009 · CA
PET Radiotracers to Evaluate Tumor Multidrug Resistance$293,316
R01 · FY2006 · CA · contact PI
PET Radiotracers to Evaluate Tumor Multidrug Resistance$45,721
R01 · FY2006 · CA · contact PI
PET Radiotracers to Evaluate Tumor Multidrug Resistance$300,375
R01 · FY2005 · CA
PET Radiotracers to Evaluate Tumor Multidrug Resistance$44,672
R01 · FY2005 · CA
PET Radiotracers to Evaluate Tumor Multidrug Resistance$292,143
R01 · FY2004 · CA
PET Radiotracers to Evaluate Tumor Multidrug Resistance$29,594
R01 · FY2004 · CA
RADIOPHARMACEUTICALS TARGETED TO TUMOR FOLATE RECEPTORS$363,578
R01 · FY2003 · CA
PET Radiotracers to Evaluate Tumor Multidrug Resistance$287,025
R01 · FY2003 · CA
RADIOPHARMACEUTICALS TARGETED TO TUMOR FOLATE RECEPTORS$352,988
R01 · FY2002 · CA
RADIOPHARMACEUTICALS TARGETED TO TUMOR FOLATE RECEPTORS$365,630
R01 · FY2001 · CA
RADIOPHARMACEUTICALS TARGETED TO TUMOR FOLATE RECEPTORS$332,723
R01 · FY2000 · CA